Skip to main content
Windlas Biotech Limited logo

Windlas Biotech Limited — Investor Relations & Filings

Ticker · WINDLAS ISIN · INE0H5O01029 LEI · 3358008HGGLMCSC4GP83 BSE.NS Manufacturing
Open in API
Filings indexed 435 across all filing types
Latest filing 2025-01-09 Regulatory Filings
Country IN India
Listing BSE.NS WINDLAS

About Windlas Biotech Limited

https://www.windlasbiotech.com

Windlas Biotech Limited is a Contract Development and Manufacturing Organization (CDMO) providing integrated services from formulation development to commercial-scale production. The company specializes in manufacturing solid and liquid oral dosage forms, including tablets, capsules, sachets, and liquid orals. Its operations encompass three primary business verticals: CDMO services for domestic and multinational firms, trade generics, and over-the-counter (OTC) brands. Windlas maintains advanced research and development facilities focused on process optimization and complex generic formulations. The product portfolio covers diverse therapeutic areas such as gastrointestinal, cardiovascular, anti-diabetic, and respiratory health. The company emphasizes scalable manufacturing solutions and adherence to global quality standards to support the product lifecycles of its pharmaceutical partners.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is addressed to stock exchanges and mentions enclosing a certificate from the Registrar and Share Transfer Agent. The document is short (1487 characters) and serves as a compliance certificate rather than a full financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it is a regulatory compliance filing rather than an annual report, quarterly report, or other detailed report. According to the rules, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS).
2025-01-09 English
Allotment of Securities
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of equity shares under employee stock option plans. It specifies the number of shares allotted under two schemes and requests the exchanges to take the information on record. The document is short (1557 characters) and serves as an announcement of a capital change related to employee stock options. It does not contain financial statements or detailed financial analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about share allotment. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2025-01-03 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a change in the company's Registrar & Share Transfer Agent (RTA) name. It does not contain financial data, management discussion, or detailed report content. The length is only 1387 characters, which is quite short and fits the profile of a regulatory announcement rather than a full report. There is no indication of financial results, audit information, or meeting materials. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous compliance announcements that do not fit other specific categories.
2025-01-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2009 characters) informing stock exchanges about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and provides details of a virtual 1x1 meeting. There is no financial data, no detailed presentation, no report attached or referenced as being published, and no voting or dividend information. The document is an announcement of an upcoming investor interaction event, not the event transcript or presentation itself. This fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure, rather than an Investor Presentation (IP) or Report Publication Announcement (RPA).
2025-01-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from Windlas Biotech Limited informing the stock exchanges about the closure of the trading window in accordance with the company's code of conduct. It mentions the trading window closure period related to the upcoming unaudited financial results for the quarter and nine months ended December 31, 2024. The document does not contain any financial data, detailed report, or analysis. It is an announcement related to compliance and trading restrictions rather than a financial report or detailed filing. The document length is only 1450 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-30 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter from Windlas Biotech Limited addressed to stock exchanges (BSE and NSE) providing clarification regarding the financial results for the period ended September 30, 2024. It references a query about the format of financial results submitted and explains the treatment of subsidiary figures and foreign currency translation. The document is short (1905 characters) and serves as a clarification or regulatory communication rather than the financial results report itself. It does not contain actual financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and clarifications that do not fit other categories.
2024-12-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.